CareLit · DOI-Nachweis · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Regulatory requirements for clinical trial and marketing authorisation application for gene therapy medicinal products
DOI 10.1007/s00103-009-0988-0
Bibliografische Angaben
Nachweis in CareLit
Autor:innenSchüle, S.; Renner, M.; Longhurst, S.; Narayanan, G.
ZeitschriftBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Ausgabe12/2009
Jahrgang / SeitenJg. 52 · S. 30 bis 37
Kernaussage aus der Literatur
Abstract-Vorschau
Over the last two decades, clinical trials using gene therapy medicinal products (GTMPs) have been carried out for a large number of rare, inherited monogeneic disorders as well as common multigeneic diseases such as cancer, cardiovascular and infectious diseases including AIDS. Despite some early difficulties and setbacks, the gene therapy field has slowly progressed and, nowadays, offers the promise of novel treat…
Zitieren
Zitierempfehlung
Schüle, S.; Renner, M.; Longhurst, S.; Narayanan, G (2009) Regulatory requirements for clinical trial and marketing authorisation application for gene therapy medicinal products. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 52 (12), 30 bis 37. https://doi.org/10.1007/s00103-009-0988-0
Mit CareLit weiterarbeiten